EP0594775A1 - Verfahren zur herstellung eines rechtsdrehenden isomeren eines isoindolinon-derivates - Google Patents

Verfahren zur herstellung eines rechtsdrehenden isomeren eines isoindolinon-derivates

Info

Publication number
EP0594775A1
EP0594775A1 EP92916240A EP92916240A EP0594775A1 EP 0594775 A1 EP0594775 A1 EP 0594775A1 EP 92916240 A EP92916240 A EP 92916240A EP 92916240 A EP92916240 A EP 92916240A EP 0594775 A1 EP0594775 A1 EP 0594775A1
Authority
EP
European Patent Office
Prior art keywords
product
oxo
formula
chloro
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP92916240A
Other languages
English (en)
French (fr)
Inventor
Marie-Thérèse David-Comte
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Rhone Poulenc Rorer SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer SA filed Critical Rhone Poulenc Rorer SA
Publication of EP0594775A1 publication Critical patent/EP0594775A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives

Definitions

  • the present invention relates to a process for the preparation of the dextrorotatory isomer of the isoindolinone derivative of formula:
  • the cyclization is carried out using thionyl chloride, optionally operating in the presence of a condensing agent such as imidazole or pyridine in an organic solvent such as methylene chloride.
  • a condensing agent such as imidazole or pyridine
  • organic solvent such as methylene chloride
  • the dextrorotatory isomer of the product of formula (II) can be obtained by resolution of the corresponding racemic by means of a chiral base. To this end, it is particularly advantageous to carry out the succession of the following operations:
  • a salt of the product of formula (II) with cinchonine in a suitable solvent such as ethanol.
  • the salt of the product of formula (II) levorotatory with cinchonine precipitates.
  • the dextrorotatory isomer of the product of formula (II) which is mainly found in the filtration mother liquors of the levorotatory salt, is transformed into an insoluble salt with cinchonidine.
  • the dextrorotatory isomer of the product of formula (II) is displaced from its salt by means of a strong acid such as hydrochloric acid.
  • the product of formula (II) in racemic form can be obtained by opening the pyrrolinone cycle of a product of formula (I) racemic in basic medium.
  • the opening of the pyrrolinone cycle is carried out using a mineral base at a temperature between 0 and 50 ° C and, preferably, between 0 and 30 ° C.
  • the process is carried out by stirring a hydro ⁇ organic solution of the product of formula (I) in the presence of an excess of mineral base chosen from hydroxides and carbonates or bicarbonates of alkali or alkaline-earth metals. It is particularly advantageous to use sodium hydroxide as a mineral base and to operate in a water-pyridine mixture. It is also possible to carry out the reaction using a water-dioxane mixture as solvent.
  • the product of formula (I) can also be obtained by the action of a mineral base on the product of formula:
  • At least two equivalents of the mineral base chosen are made to act, preferably from soda, potash, sodium carbonate or potassium carbonate, operating in water or in a hydro-organic medium with a temperature between 0 and 50 ° C, preferably between 0 and 30 ° C.
  • a hydro-organic medium a dioxane-water mixture is preferably used.
  • the product of formula (III) can be obtained by hydrolysis in acid medium of a product of general formula:
  • R represents an alkyl radical containing 1 to 10 carbon atoms in a straight or branched chain.
  • the hydrolysis is carried out using a strong mineral acid such as concentrated sulfuric acid, operating at a temperature between 0 and 50 ° C, preferably close to 20 ° C.
  • a strong mineral acid such as concentrated sulfuric acid
  • the dextrorotatory isomer of ⁇ [(7-chloro-naphthyridin-1,8 yl-2 amino] -1-methyl-6 oxo-3 heptyl ⁇ -2 benzoic acid can be prepared by one of the following methods:
  • a white product consisting mainly of the dextrorotatory isomer of ⁇ [(7-chloro-naphthyridine-1,8 yl-2) amino] -1 methyl-6-oxo-3 heptyl ⁇ -2 benzoic with the following characteristics:
  • the suspension obtained is filtered.
  • the precipitate obtained is washed with 5 times 100 cm3 of distilled water and then dried at 60 ° C for 16 hours under reduced pressure (15 mm of mercury; 2.0 kPa).
  • Benzoic ⁇ [(7-chloro-naphthyridine-1,8 yl-2) amino] -1-6-methyl-3-oxo-heptyl ⁇ -2 acid can be prepared by one of the following methods:
  • the solid obtained is taken up in 3.8 liters of distilled water and 480 cm3 of an aqueous 0.1N sodium hydroxide solution.
  • the precipitate obtained is separated by filtration, washed with distilled water and then with isopropyl ether and dried at 20 ° C under reduced pressure (0.07 kPa).
  • 9.2 g of [(chloro-7 naphthyridine-1,8 yl-2) -2 oxo-3 isoindolinyl-1] -2 methyl-6-oxo-3 heptanoic acid, melting at 176 ° C., are thus obtained.
  • Ethyl [(chloro-7 naphthyridine-1,8 yl-2) -2 oxo-3 isoindolinyl-1] -2 methyl-6 oxo-3 heptanoate can be obtained by the method described in US patent US 4,960 779.
  • EXAMPLE 2 118.3 g of (+) - e ⁇ hedrine salt and ⁇ [(7-chloro-naphthyridine-1,8 yl-2) amino] -l methyl- acid are introduced into a 2.5-liter reactor. 6 oxo-3 heptyl ⁇ -2 beno zoic and 1700 cm3 of methylene chloride. The organic solution is washed, at 20 ° C., with 400 cm3 of an aqueous 0.5N hydrochloric acid solution and then with 400 cm3 of distilled water. The organic phase is dehydrated by azeotropic distillation at 20 ° C under reduced pressure (250 mm of mercury; 33.3 kPa).
  • the volume of the organic phase is adjusted to 1700 cm3 by addition of dry methylene chloride, then 95.2 g of imidazole are added and then, in 10 minutes, 25 cm3 of thionyl chloride.
  • the suspension is heated at 40 ° C for 30 minutes then cooled to 20 ° C and washed with 2 times 700 cm3 of distilled water.
  • the methylene chloride is removed by distillation under atmospheric pressure while adding, at constant volume, 2500 cm 3 of absolute ethanol. When the temperature of the vapors reaches 78 ° C., the distillation is stopped, then 4 g of bleaching black suspended in 20 cm 3 of absolute ethanol are added. The mixture is left for 30 minutes at 78 ° C. and then filtered while hot.
  • the bleaching black is rinsed with 200 cm3 of ethanol at 77 ° C.
  • the washing and the filtrate are combined and then cooled, at a speed of 20 ° C / hour, at a temperature of 10 ° C.
  • the suspension is filtered.
  • the precipitate is washed with 3 times 140 cm 3 of absolute ethanol at 10 ° C and then dried at 60 ° C for 16 hours under reduced pressure (15 mm of mercury; 2.0 kPa).
  • the slightly yellow product obtained (68.9 g) is recrystallized from 1400 cm3 of ethanol at reflux. After cooling to 10 ° C, the suspension is filtered.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
EP92916240A 1991-07-12 1992-07-10 Verfahren zur herstellung eines rechtsdrehenden isomeren eines isoindolinon-derivates Withdrawn EP0594775A1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9108830 1991-07-12
FR9108830A FR2678934B1 (fr) 1991-07-12 1991-07-12 Procede de preparation de l'isomere dextrogyre d'un derive de l'isoindolinone.
PCT/FR1992/000666 WO1993001187A1 (fr) 1991-07-12 1992-07-10 Procede de preparaton de l'isomere dextrogyre d'un derive de l'isoindolinone

Publications (1)

Publication Number Publication Date
EP0594775A1 true EP0594775A1 (de) 1994-05-04

Family

ID=9415049

Family Applications (2)

Application Number Title Priority Date Filing Date
EP92916240A Withdrawn EP0594775A1 (de) 1991-07-12 1992-07-10 Verfahren zur herstellung eines rechtsdrehenden isomeren eines isoindolinon-derivates
EP92402007A Pending EP0522972A1 (de) 1991-07-12 1992-07-10 Verfahren zur Herstellung eines rechtsdrehenden Isomeren eines Isoindolinon-Derivats

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP92402007A Pending EP0522972A1 (de) 1991-07-12 1992-07-10 Verfahren zur Herstellung eines rechtsdrehenden Isomeren eines Isoindolinon-Derivats

Country Status (13)

Country Link
EP (2) EP0594775A1 (de)
JP (1) JPH06509083A (de)
KR (1) KR100235373B1 (de)
AU (1) AU658662B2 (de)
CA (1) CA2112980C (de)
FR (1) FR2678934B1 (de)
IE (1) IE72500B1 (de)
IL (1) IL102446A0 (de)
MA (1) MA22589A1 (de)
MX (1) MX9204054A (de)
NZ (1) NZ243494A (de)
WO (1) WO1993001187A1 (de)
ZA (1) ZA925099B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU783516B2 (en) 2001-04-30 2005-11-03 Warner-Lambert Company Methods, kits and compositions for using pyrrole derivatives
IL164377A0 (en) 2002-03-29 2005-12-18 Indevus Pharmaceuticals Inc Methods of preparation of the 2-(7-chloro-1,8-naphthyridine-2yl)-3-(5-methyl-2-oxo-hexyl)-1-isoindolinone

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2313060A1 (fr) * 1974-11-07 1976-12-31 Rhone Poulenc Ind Nouveaux derives de l'isoindoline, leur preparation et les compositions qui les contiennent
FR2321290A1 (fr) * 1975-04-07 1977-03-18 Rhone Poulenc Ind Nouveaux derives de l'isoindoline, leur preparation et les compositions qui les contiennent
FR2607503B1 (fr) * 1986-12-02 1989-02-24 Rhone Poulenc Sante Nouveaux derives de l'isoindolinone, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2678933B1 (fr) * 1991-07-12 1993-09-24 Rhone Poulenc Rorer Sa Procede de preparation des isomeres optiques d'un derive de l'amino-2 naphtyridine.
FR2678932B1 (fr) * 1991-07-12 1993-09-24 Rhone Poulenc Rorer Sa Procede de preparation des isomeres optiques d'un derive de l'amino-2 naphtyridine.
FR2678931B1 (fr) * 1991-07-12 1993-09-24 Rhone Poulenc Rorer Sa Nouveau derive de l'amino-2 naphtyridine, sa preparation et son emploi.

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9301187A1 *

Also Published As

Publication number Publication date
IE72500B1 (en) 1997-04-23
FR2678934A1 (fr) 1993-01-15
CA2112980C (fr) 2003-09-30
KR100235373B1 (ko) 1999-12-15
AU658662B2 (en) 1995-04-27
FR2678934B1 (fr) 1995-01-13
AU2360692A (en) 1993-02-11
MX9204054A (es) 1993-07-01
CA2112980A1 (fr) 1993-01-21
ZA925099B (en) 1993-04-28
WO1993001187A1 (fr) 1993-01-21
JPH06509083A (ja) 1994-10-13
MA22589A1 (fr) 1993-04-01
IL102446A0 (en) 1993-01-14
EP0522972A1 (de) 1993-01-13
IE922238A1 (en) 1993-01-13
NZ243494A (en) 1995-03-28

Similar Documents

Publication Publication Date Title
CA1222246A (fr) Procede pour la preparation de la 4,5-dihydro imidazo ¬4,5,1-j-k|¬1| benzazepin-2,7-(1h,6h)-dione et le produit ainsi obtenu
MC807A1 (fr) Procédé de préparation de 3-alcoxy-thianaphtene-carboxamide substituées ou non
EP0729933B1 (de) Trizyklische Derivate, ihre Herstellung, ihre Verwendung zur Herstellung von optisch aktivem oder racemischem Colchizin, Thiocolchizin, dessen Analoge oder Derivate, und Intermediate
EP0598765B1 (de) 2-aminonaphthyridin-derivat, seine herstellung und verwendung
CA2112981C (fr) Procede de preparation des isomeres optiques d'un derive de l'amino-2 naphtyridine
WO1991019714A1 (fr) Nouveaux derives de l'oxazole, leur preparation et les compositions pharmaceutiques qui les contiennent
EP0594775A1 (de) Verfahren zur herstellung eines rechtsdrehenden isomeren eines isoindolinon-derivates
CA2112982C (fr) Procede de preparation des isomeres optiques d'un derive de l'amino-2 naphtyridine
CA1038374A (fr) Derives de la cephalosporine, leur preparation et les compositions qui les contiennent
CA1112642A (fr) Derives de l'isoquinoleine, leur preparation et les compositions qui les contiennent
EP0517591A1 (de) Oxazolederivate und ihre Herstellung
EP0233801B1 (de) Substituierte Amide, ihre Herstellung und diese enthaltende pharmazeutische Zubereitungen
EP0517590A1 (de) Oxazolederivate, ihre Herstellung und sie enthaltende Zusammensetzungen
FR2684673A1 (fr) Procede de preparation d'un derive de l'amino-2 naphtyridine racemique.
EP0534814A1 (de) Verfahren zur Herstellung eines rechtsdrehenden Isomeren eines Derivats des Isoindolins
FR2516512A1 (fr) Nouveaux derives pyridoindoliques, leur procede de preparation et les compositions pharmaceutiques en contenant
CH617704A5 (de)
FR2518998A1 (fr) Nouveaux derives heterocycliques d'acide acetique et procede pour leur preparation
CH618174A5 (de)
FR2650277A1 (fr) Nouveaux derives de benzonaphtyridine-1,8 et leur preparation
CH487104A (fr) Procédé de préparation de nouveaux dérivés de l'acide benzoyl-3 phénylacétique
CH356453A (fr) Procédé de préparation de nouvelles phénothiazines
CH619464A5 (en) Process for the preparation of new 1,2-dithiole derivatives

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19940107

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE

XX Miscellaneous (additional remarks)

Free format text: VERBUNDEN MIT 92402007.6/0522972 (EUROPAEISCHE ANMELDENUMMER/VEROEFFENTLICHUNGSNUMMER) DURCH ENTSCHEIDUNG VOM 13.05.94.

17Q First examination report despatched

Effective date: 19941214

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Withdrawal date: 19950324